(NIH/National Institute of General Medical Sciences) NIH plans to spend $161.3 million over the next five years to expand the nationwide Pharmacogenomics Research Network. Since its launch in 2000, the network has studied how genes affect individual responses to medicines for heart disease, asthma, various cancers, nicotine addiction and other conditions. In addition to these areas, the expanded network will focus on rheumatoid arthritis, bipolar disorder and the use of pharmacogenetics in rural and underserved populations.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Medicine
- Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Vir
- Differences in Acinetobacter baumannii Strains and Host Innate Immune Response Determine Morbidity and Mortality in Experimental
- Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types
- Two-Item Sentence Comprehension by a Dog (Canis familiaris)
- Risks of pregnancy via egg donation similar for women over age 50 as for younger women